Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–108 of 108 matching trials from the live ClinicalTrials.gov search.

Conditions: Upper Eyelid Surgery
Interventions: Hyaluronidase, 2 mL of lidocaine 2% with epinephrine 1:100,000 without rHuPH20; Drug · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chronic Subdural Hematoma
Interventions: embolization therapy Bilateral, embolization therapy Unilateral; Device
Lead sponsor: Lahey Clinic; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Burlington, Massachusetts

Conditions: Respiratory Insufficiency
Interventions: Experimental ET Tube Securement Device; Other
Lead sponsor: Hollister Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 5
States / cities: Hartford, Connecticut • Washington D.C., District of Columbia • Tampa, Florida + 2 more

Conditions: Ipsilateral Shoulder Pain
Interventions: Sphenopalatine Ganglion (SPG) Block, lidocaine; Procedure · Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Surgery, Anesthesia
Interventions: Haider ETT Tube Holder and Bite Guard, Tape; Device · Procedure
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Breast - Female
Interventions: Transversus Abdominis Plane (TAP) block, Nimbus Infusion Pump IV Administration, Bupivacaine infusion, Acetominophen, Hydromorphone, Oxycodone, Ondansetron; Procedure · Device · Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: Peripheral Arterial Disease
Interventions: Chronic TOtAl OcclusioN CrossiNg with thE WildCat CatheTer; Device
Lead sponsor: Avinger, Inc.; Industry
Eligibility: 19 Years and older
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 15
States / cities: Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 10 more

Conditions: Pelvic Organ Prolapse, Post Operative Pain
Interventions: Quadratus Lumborum (QL) Block, Enhanced Recovery After Surgical (ERAS) Protocol; Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Kidney Transplant; Complications, Pain, Postoperative
Interventions: Intravenous Lidocaine, Transversus abdominis plane (TAP) block, Quadratus Lumborum (QL) Block; Drug
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Search by objective public record fields.